Assessing glaucoma deterioration using Spaeth/Richman contrast sensitivity test
- PMID: 33447729
- PMCID: PMC7780179
- DOI: 10.1177/2515841420977412
Assessing glaucoma deterioration using Spaeth/Richman contrast sensitivity test
Abstract
Purpose: To assess changes in the central and peripheral contrast sensitivity in severe primary open-angle glaucoma (POAG) patients using a computer-based Spaeth/Richman contrast sensitivity test (SPARCS) over a period of 24 months.
Methods: Our pilot, observational study included 15 patients (30 eyes) with severe POAG. Visual acuity, intraocular pressure, number of anti-glaucoma drugs, visual fields, and SPARCS score were recorded at first visit and at 12 and 24 months.
Results: We observed changes in mean deviation (MD) from -19.37 ± 5.04 to -20.63 ± 4.07, mean pattern standard deviation (PSD) from 11.49 ± 2.61 to 11.35 ± 2.01, and mean SPARCS score from 54.97 ± 15.66 to 53.50 ± 16.42. We found no statistically significant difference between visual field parameters and SPARCS scores associated with the number or type of prescribed anti-glaucoma drugs. Spearman's correlation coefficient of SPARCS at baseline (SPARCS1) versus MD at baseline (MD1) was 0.274 (p = 0.142) and SPARCS1 versus PSD at baseline (PSD1) was -0.163 (p = 0.389). The correlation coefficient between SPARCS at 12 months (SPARCS2) versus MD (MD2) at the same time point was computed to be 0.391 (p = 0.03), whereas SPARCS2 versus PSD at 12 months was -0.212 (p = 0.262). Similarly, we found the coefficient to be 0.336 (p = 0.069) for SPARCS3 (SPARCS at 24 months) versus MD3 (MD at 24 months) and -0.242 (p = 0.197) for SPARCS3 versus PSD3 (PSD at 24 months). Correlation coefficients between SPARCS1/2, SPARCS1/3, MD1/2, MD1/3 PSD1/2, and PSD1/3 were 0.856, 0.865, 0.748, 0.722, 0.497, and 0.562, respectively (p < 0.001). MD changed by 9.46% ± 12.73%, PSD by 0.64% ± 14.03%, and average SPARCS by 3.31% ± 12.73% over 24 months.
Conclusion: The data from our study indicate the utilitarian application of SPARCS, an inexpensive and readily available tool for monitoring functional deterioration in cases with advanced glaucomatous damage, especially in resource-poor settings. Furthermore, it is a useful and reliable alternative to the imaging modalities where retinal nerve fiber layer measurement can be erroneous in advanced cases secondary to the floor effect.
Keywords: Spaeth/Richman contrast sensitivity test; contrast sensitivity; glaucoma.
© The Author(s), 2020.
Conflict of interest statement
Conflict of interest statement: The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Figures
Similar articles
-
Spaeth/Richman Contrast Sensitivity in Staging Glaucoma.Transl Vis Sci Technol. 2020 Dec 22;9(13):39. doi: 10.1167/tvst.9.13.39. eCollection 2020 Dec. Transl Vis Sci Technol. 2020. PMID: 33384893 Free PMC article.
-
Analysing the change in contrast sensitivity post-travoprost treatment in primary open-angle glaucoma patients using Spaeth Richman contrast sensitivity test.Int Ophthalmol. 2023 Jun;43(6):2037-2047. doi: 10.1007/s10792-022-02603-z. Epub 2022 Nov 29. Int Ophthalmol. 2023. PMID: 36445547
-
Assessment of contrast sensitivity by Spaeth Richman Contrast Sensitivity Test and Pelli Robson Chart Test in patients with varying severity of glaucoma.Eye (Lond). 2018 Aug;32(8):1392-1400. doi: 10.1038/s41433-018-0099-y. Epub 2018 May 14. Eye (Lond). 2018. PMID: 29755121 Free PMC article.
-
[Aiming for zero blindness].Nippon Ganka Gakkai Zasshi. 2015 Mar;119(3):168-93; discussion 194. Nippon Ganka Gakkai Zasshi. 2015. PMID: 25854109 Review. Japanese.
-
Suitability of the Visual Field Index according to Glaucoma Severity.J Curr Glaucoma Pract. 2015 Sep-Dec;9(3):65-8. doi: 10.5005/jp-journals-10008-1186. Epub 2016 Feb 2. J Curr Glaucoma Pract. 2015. PMID: 26997838 Free PMC article. Review.
Cited by
-
Qualitative Development of the Allergan Satisfaction with Treatment Experience Questionnaire (ASTEQ) Instrument, a Patient-Reported Outcome Measure in Glaucoma and Ocular Hypertension.Ophthalmol Ther. 2024 Jan;13(1):71-92. doi: 10.1007/s40123-023-00804-y. Epub 2023 Sep 22. Ophthalmol Ther. 2024. PMID: 37737923 Free PMC article.
-
Assessment of glaucoma severity and deterioration by using Spaeth/Richman contrast sensitivity (SPARCS) and its correlation with retinal nerve fiber layer thickness and perimetry.Indian J Ophthalmol. 2025 Mar 1;73(Suppl 2):S282-S286. doi: 10.4103/IJO.IJO_2289_23. Epub 2024 May 20. Indian J Ophthalmol. 2025. PMID: 38767552 Free PMC article.
References
-
- de Moraes CG, Liebmann JM, Medeiros FA, et al. Management of advanced glaucoma: characterization and monitoring. Surv Ophthalmol 2016; 61: 597–615. - PubMed
-
- Hawkins AS, Szlyk JP, Ardickas Z, et al. Comparison of contrast sensitivity, visual acuity, and Humphrey visual field testing in patients with glaucoma. J Glaucoma 2003; 12: 134–138. - PubMed
LinkOut - more resources
Full Text Sources